Literature DB >> 11092246

Endogenous lectins as cell surface transducers.

E Hébert1.   

Abstract

Interactions between cells or between cell and substratum involve specific receptors and their ligands. Among the various cell surface receptors identified during the last decades, the carbohydrate-binding proteins, e.g., lectins are of peculiar interest because glycolipids, glycoproteins and proteoglycans have been shown to interact with lectins on the surface of animal cells. Animal lectins are recognized as molecules playing important roles in a variety of biological processes through binding to glycoconjugates and lectin-like receptors such as selectins, sialoadhesins (CD22, CD33), natural killer receptors (NKR-P1, CD69 and CD94/NKG2), hyaluronate receptors (CD44, RHAMM, ICAM-1), B-cell associated antigen (CD23, CD72), beta2 leukocyte integrin (CD11b/CD18) or the well-known receptors for mannose, mannose-6-phosphate or asialoglycoprotein have been suggested to be able to mediate the transfer of information from the outside to the inside of the cell. This review focuses on the most recent advances in our understanding of the molecular basis of "outside-in" signaling mediated by lectins. Lectin-like receptors are involved in signal transduction in a great variety of ways; at the molecular level, they mimic in most of the cases the function of growth factor receptor either coupled to tyrosine kinase activity or to heterotrimeric G protein. They lead to a multiplicity of cellular events following their activation depending on factors such as cellular type, species and/or tissue. Nevertheless the potential of surface lectins as transducers is emphasized by the observation that in a few cases lectin-like receptors induce either novel signal transduction mechanism or new intracellular events with regards to what it has been observed as a consequence of growth factor receptor activation. This observation brings the idea that lectins may offer, as cell surface transducers, an alternative or additional signaling potential to cell.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092246     DOI: 10.1023/a:1026484722248

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  6 in total

1.  Isolation of osteoprogenitors from murine bone marrow by selection of CD11b negative cells.

Authors:  A Dumas; M A Le Drévo; M F Moreau; C Guillet; M F Baslé; D Chappard
Journal:  Cytotechnology       Date:  2009-02-17       Impact factor: 2.058

2.  Identification of Lectins from Metastatic Cancer Cells through Magnetic Glyconanoparticles.

Authors:  Herbert W Kavunja; Patricia G Voss; John L Wang; Xuefei Huang
Journal:  Isr J Chem       Date:  2015-03-23       Impact factor: 3.333

3.  Lectin extracted from Canavalia grandiflora seeds presents potential anti-inflammatory and analgesic effects.

Authors:  Breno S Nunes; Nathalie S Rensonnet; Daniela Dal-Secco; Silvio M Vieira; Benildo S Cavada; Edson H Teixeira; Tales R Moura; Cícero S Teixeira; Juliana T Clemente-Napimoga; Fernando Q Cunha; Marcelo H Napimoga
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-20       Impact factor: 3.000

4.  Chip-based comparison of the osteogenesis of human bone marrow- and adipose tissue-derived mesenchymal stem cells under mechanical stimulation.

Authors:  Sang-Hyug Park; Woo Young Sim; Byoung-Hyun Min; Sang Sik Yang; Ali Khademhosseini; David L Kaplan
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

5.  Carbohydrate microarrays for screening functional glycans.

Authors:  Jaeyoung Pai; Ji Young Hyun; Jieun Jeong; Sohee Loh; Eun-Hee Cho; Young-Sun Kang; Injae Shin
Journal:  Chem Sci       Date:  2016-01-05       Impact factor: 9.825

6.  Characterization of a Novel Bispecific Antibody That Activates T Cells In Vitro and Slows Tumor Growth In Vivo.

Authors:  Olesya Chornoguz; Catherine N Leettola; Karen Leander; Kerry Brosnan; Eva Emmell; Mark L Chiu; Sandra Santulli-Marotto
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2019-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.